Physician profile

Edward W Chu

Cardiovascular Disease · South Miami, FL

NPI 1881031045

$86,158.53

in general payments reported to CMS, 2019-2025

31 companies · $16K in 2025

The $16K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$20,681.49
Travel and Lodging$10,212.04
Consulting Fee$6,875.00
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$4,625.00
Honoraria$1,500.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $29,410.12 2019-2025 Ensite, Aveir, Ensite Precision
Boston Scientific Corporation $23,966.90 2019-2025 General - Therapies, Farapulse, Watchman Flx
Medtronic, INC. $17,423.14 2021-2025 Diamondtemp Bidirectional Ablation Catheter, Cobalt Dr Mri Surescan, Micra
Atricure, INC. $4,092.88 2022-2025 Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Synergy Ablation System
Medtronic Vascular, INC. $2,669.99 2019-2020
Altathera Pharmaceuticals LLC $1,636.15 2023 Sotalol Hydrochloride
Biotronik INC. $1,513.85 2022-2024
Cardiva Medical, INC. $1,352.22 2022-2025 Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f, Savvywire
Biosense Webster, INC. $997.59 2021-2024 Carto 3
Impulse Dynamics (USA) INC. $881.59 2022-2024 Optimizer, Optimizer
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $288.53 2019-2023 Lifevest
Silk Road Medical, INC. $179.93 2022
Baxter Healthcare $175.88 2022
Amgen INC. $162.55 2019
Cardiofocus, INC. $159.64 2022-2023 Heartlight System
Show all 31 companies
CompanyGeneral paymentsYearsTop products
Elutia, INC. $141.48 2024 Ecm Patch,Pouch
Edwards Lifesciences Corporation $135.00 2024
Astrazeneca Pharmaceuticals LP $130.45 2019
Philips North America LLC $130.25 2022
Terumo Medical Corporation $114.17 2024 Azur Cx Detachable
Kestra Medical Technology Services, INC. $110.23 2025 Assure Wcd
Pfizer INC. $83.14 2023-2024
Abiomed $71.92 2019
E.R. Squibb & Sons, L.L.C. $61.61 2025 Eliquis, Camzyos
Braemar Manufacturing, LLC $55.26 2019
Acutus Medical, INC. $49.29 2021-2022
La Jolla Pharmaceutical Company $42.93 2025 Giapreza
Heartflow, INC. $42.92 2024
Novartis Pharmaceuticals Corporation $35.42 2022-2023
Zoll Circulation INC $25.74 2023 Catheter, Therox Ds2 Console, Downstream Cartridge
Cvrx, INC. $17.76 2024 Barostim Neo System

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Edward W Chu

$86,158.53

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $16K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/900828/edward-w-chu

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.